IP Library Granted Patent US 12674197
Granted Patent B2
US 12674197 · App. 17/426,136 · Granted Jul 7, 2026

Process for producing a chromatin conformation capture (3C) library

Inventors: James Davies (Oxford, GB); James R. Hughes (Oxford, GB)
Assignee: OXFORD UNIVERSITY INNOVATION LIMITED
C12Q1/6858C12Q1/6806
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12674197
App. No.
17/426,136
Granted
Jul 7, 2026
Kind
B2
Abstract

The present invention relates to a process for producing a chromatin conformation capture (3C) library. This may be used for identifying nucleic acid regions within a nucleic acid sample which interact with one another. The process comprises treating nucleic acids in a population of eukaryotic cells, the process comprising the steps: (i) immobilising the nucleic acids within the cells in a population of eukaryotic cells; (ii) permeabilising or removing the cell membranes of the eukaryotic cells; and (iii) fragmenting the immobilised nucleic acids within the cells to produce nucleic acid fragments.

Claims (25)

1 . A method comprising producing nucleic acids with unlabeled ends, comprising:

(a) treating chromatin in a population of eukaryotic cells by:

(i) immobilising the chromatin within the cells in the population of eukaryotic cells;

(ii) permeabilising or removing cell membranes of the eukaryotic cells; and

(iii) fragmenting the immobilised chromatin within the cells to produce nucleic acids with unlabeled ends comprising >70% mono-nucleosomes of 180-200 bp;

(b) ligating the nucleic acids with unlabeled ends comprising the mono-nucleosomes of 180-200 bp to produce ligated nucleic acid fragments; and

(c) de-immobilising the ligated nucleic acid fragments.

2 . The method of claim 1 , wherein in Step (i), the chromatin is immobilised by cross-linking the chromatin.

3 . The method of claim 1 , wherein:

(a) the outer cell membranes and nuclear membranes are permeabilised;

(b) the outer cell membranes and/or nuclear membranes are not lysed;

(c) the outer cell membranes or nuclear membranes are not completely removed;

(d) the outer cell membranes and nuclear membranes of the cells are permeabilised without removing the outer cell membranes or nuclear membranes;

(e) the cell membranes are removed and the nuclear membranes are permeabilised but not removed;

(f) the cell membranes are removed and the nuclear membranes are removed; or

(g) the process comprises (ii) permeabilising the cell membranes of the eukaryotic cells; and (iii) fragmenting the immobilised chromatin within the cells to produce nucleic acid fragments.

4 . The method of claim 1 , wherein in Step (iii), the immobilised chromatin is fragmented using an endo-exonuclease or using micrococcal nuclease.

5 . The method of claim 1 , wherein in Step (iii), the immobilised chromatin is fragmented such that mono-nucleosomes are produced, wherein the inter-nucleosomal linkers are not digested to completion.

6 . The method of claim 1 , wherein the eukaryotic cells are mammalian cells and wherein the number of cells in the population of mammalian cells is 1-10,000, 10,000-1 million, or 1 million to 100 million.

7 . A kit for identifying nucleic acid regions within a nucleic acid sample which interact with one another, the kit comprising buffers and reagents for performing a method as defined in claim 1 .

8 . The method of claim 1 , wherein the eukaryotic cells are mammalian cells.

9 . The method of claim 1 , wherein the fragmenting in step (iii) is carried out using micrococcal nuclease.

10 . The method of claim 1 , wherein the fragmenting is performed without use of a restriction endonuclease.

11 . The method of claim 1 , wherein the fragments comprise mono-nucleosomes and linkers that are not digested to completion.

12 . The method of claim 6 , wherein the mammal is a human.